Azaperone, a sedative neuroleptic of the butyrophenone series with pronounced anti-aggressive and anti-shock activity in animals.
D000374:Aggression / Q000187:drug effects*; D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001833:Body Temperature Regulation / Q000187:drug effects; D002090:Butyrophenones / Q000494:pharmacology* / Q000633:toxicity; D004285:Dogs; D004357:Drug Synergism; D005106:Exploratory Behavior / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D010424:Pentobarbital / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology / Q000633:toxicity; D011725:Pyridines / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D011930:Reaction Time / Q000187:drug effects; D012025:Reflex, Pupillary / Q000187:drug effects; D012774:Shock, Traumatic / Q000517:prevention & control*
D002090:Butyrophenones; D010879:Piperazines; D011725:Pyridines; D000661:Amphetamine; D010424:Pentobarbital